T1	chemical 78 82	drug
T2	disease_or_phenotypic_feature 105 119	ovarian cancer
T3	disease_or_phenotypic_feature 121 138	colorectal cancer
T4	disease_or_phenotypic_feature 144 158	gastric cancer
T5	disease_or_phenotypic_feature 177 190	Heart failure
T6	disease_or_phenotypic_feature 216 235	myocardial ischemia
T7	disease_or_phenotypic_feature 237 247	arrhythmia
T8	chemical 263 267	drug
T9	chemical 289 293	drug
T10	chemical 352 358	sodium
T11	disease_or_phenotypic_feature 364 370	anemia
T12	chemical 384 392	hormones
T13	disease_or_phenotypic_feature 396 403	obesity
T14	disease_or_phenotypic_feature 425 432	neuroma
T15	disease_or_phenotypic_feature 433 437	pain
T16	chemical 452 460	solution
T17	chemical 470 474	talc
T18	disease_or_phenotypic_feature 517 534	ovarian carcinoma
T19	chemical 585 592	ghrelin
T20	disease_or_phenotypic_feature 638 645	obesity
T21	chemical 650 654	food
T22	chemical 699 706	trypsin
T23	chemical 707 716	inhibitor
T24	disease_or_phenotypic_feature 720 734	gastric cancer
T25	chemical 767 774	Dextran
T26	chemical 775 782	sulfate
T27	chemical 783 789	sodium
T28	disease_or_phenotypic_feature 798 805	colitis
T29	disease_or_phenotypic_feature 940 943	MPa
T30	chemical 945 956	"ARG4.0MPa"
T31	disease_or_phenotypic_feature 945 956	"ARG4.0MPa"
T32	disease_or_phenotypic_feature 1032 1037	tumor
T33	chemical 1087 1096	molecular
T34	disease_or_phenotypic_feature 1174 1186	mixed tumors
T35	chemical 1240 1247	antigen
T36	disease_or_phenotypic_feature 1249 1254	Tumor
T37	chemical 1279 1297	apoptosis-inducing
T38	chemical 1298 1304	ligand
T39	disease_or_phenotypic_feature 1411 1417	cancer
T40	chemical 1507 1518	methylation
T41	disease_or_phenotypic_feature 1633 1640	PPP2R2B
T42	chemical 1670 1681	Amphetamine
T43	disease_or_phenotypic_feature 1790 1797	obesity
T44	chemical 1821 1827	Fibrin
T45	disease_or_phenotypic_feature 1851 1856	Blood
T46	chemical 1932 1943	biochemical
T47	disease_or_phenotypic_feature 1961 1973	brain tumors
T48	chemical 2016 2025	gefitinib
T49	disease_or_phenotypic_feature 2040 2052	glioblastoma
T50	disease_or_phenotypic_feature 2137 2161	Cutaneous pseudolymphoma
T51	chemical 2196 2206	inhibitors
T52	chemical 2226 2237	ustekinumab
T53	chemical 2376 2384	ion-pair
T54	disease_or_phenotypic_feature 2376 2384	ion-pair
T55	chemical 2396 2401	lipid
T56	chemical 2553 2563	inhibitors
T57	disease_or_phenotypic_feature 2567 2589	ankylosing spondylitis
T58	missed_chemical 28 62	ntraperitoneal chemotherapy agents
R1	treats Arg1:T58 Arg2:T2	
R2	treats Arg1:T58 Arg2:T3	
R3	treats Arg1:T58 Arg2:T4	
R4	causes_or_contributes_to Arg1:T8 Arg2:T5	
T59	missed_chemical 317 330	beta-blockers
R5	causes_or_contributes_to Arg1:T10 Arg2:T5	
R6	causes_or_contributes_to Arg1:T59 Arg2:T5	
R7	causes_or_contributes_to Arg1:T17 Arg2:T18	
R8	causes_or_contributes_to Arg1:T19 Arg2:T20	
T60	missed_chemical 673 694	plasminogen activator
T61	corrected_chemical 699 716	trypsin inhibitor
T62	missed_disease_or_phenotypic_feature 736 741	ulcer
T63	missed_disease_or_phenotypic_feature 759 764	tumor
R9	treats Arg1:T60 Arg2:T24	
R10	treats Arg1:T60 Arg2:T62	
R11	treats Arg1:T60 Arg2:T63	
R12	treats Arg1:T61 Arg2:T24	
R13	treats Arg1:T61 Arg2:T62	
R14	treats Arg1:T61 Arg2:T63	
T64	missed_disease_or_phenotypic_feature 817 826	neoplasia
T65	corrected_chemical 767 789	Dextran sulfate sodium
R15	causes_or_contributes_to Arg1:T65 Arg2:T64	
R16	treats Arg1:T42 Arg2:T43	
T66	missed_disease_or_phenotypic_feature 1755 1772	attention deficit
T67	missed_disease_or_phenotypic_feature 1774 1784	narcolepsy
R17	treats Arg1:T42 Arg2:T66	
R18	treats Arg1:T42 Arg2:T67	
R19	treats Arg1:T48 Arg2:T49	
